Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dactinomycin compositions and methods for the treatment of acute myeloid leukemia

Dactinomycin compositions and methods for the treatment of acute myeloid leukemia

US Patent 11337983 · Granted May 24, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of an arsenic compound and at least one retinoid for treating acute 2021
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2019
Dactinomycin compositions and methods for the treatment of acute myeloid leukemi2019
Dactinomycin compositions and methods for the treatment of acute myeloid leukemi2019
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2018
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2017
Method for monitoring minimal residual hairy cell leukemia2015
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2013
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2012